MRF has reclaimed its position as India's most expensive stock. A single share of the company has reached ₹1,37,834. This surpasses the previous record held by Elcid Investment, whose share price once surged from ₹3.53 to ₹2.36 lakh in a single day. MRF also delivered a b financial performance in the March quarter.
MRF Share Price Performance
MRF has once again secured the title of the most expensive stock on the Indian stock market. The price of a single share has reached ₹1,37,834, second only to Elcid Investment's previous record. Elcid Investment created a record in October 2024, rapidly increasing from ₹3.53 to ₹2.36 lakh, but its share price has currently settled around ₹1.29 lakh.
MRF's share price saw a 1.9% decline on Tuesday (June 3rd) and a 3.34% decrease throughout the week. However, the company's share gained 3.24% in May. Over the past two months, MRF's share price has increased by 22.54%. Year-to-date (YTD) from the beginning of 2025, the share has seen a 5.7% increase.
MRF's 52-week high was ₹1,47,000 (May 26, 2025), and its low was ₹1,02,000 (March 5, 2025).
Improved Financial Performance
MRF presented solid financial results for the March quarter of fiscal year 2024-25. The company's consolidated net profit increased by 33 percent to ₹492.74 crore, compared to ₹370.52 crore in the same period last year. During this period, the company's total operational income was ₹7,074.82 crore, an 11.4 percent increase year-on-year.
Operating profit (EBITDA) also increased by 17.8 percent to ₹1,043 crore, compared to ₹885 crore last year. The company's operating margin was 15 percent, better than the 14.3 percent recorded last year.
MRF vs Elcid Investment
![]()
While Elcid Investment's price surge was exceptionally rapid, a "flash spike," MRF's position remains b in terms of stability and reliability. MRF's robust business model, brand value, and larger market capitalization differentiate it from smaller-volume, small-cap stocks like Elcid.
MRF's b long-term performance and consistently improving financial health make it a robust and reliable investment option in the Indian stock market. In contrast, Elcid Investment's rapid price increase has proven volatile and erratic.












